Related Experiment Video
Updated: Jan 7, 2026

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis
Published on: May 10, 2022
Meta-Analysis: Prevalence of Eating Disorders in Inflammatory Bowel Disease
Quinn Goddard1,2, Ante Markovinović1,2, Paul E Ronksley2
1Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Eating disorders are common in inflammatory bowel disease (IBD) patients, especially avoidant/restrictive types. Increased clinical awareness and screening are crucial for better detection and management of disordered eating in this population.
Area of Science:
- Gastroenterology
- Psychiatry
- Public Health
Background:
- The relationship between disordered eating and inflammatory bowel disease (IBD) remains unclear, with ongoing debate about causality.
- Existing research lacks comprehensive estimates of eating disorder prevalence within the IBD population.
Purpose of the Study:
- To conduct an updated systematic review and the first meta-analysis to determine the prevalence of eating disorders in individuals diagnosed with IBD.
- To identify factors influencing prevalence estimates, such as assessment methods and patient demographics.
Main Methods:
- Systematic search of major biomedical databases (MEDLINE, Embase, PsycINFO) up to October 2025.
- Inclusion of original observational studies reporting eating disorder prevalence in IBD patients.
- Calculation of pooled prevalence using random-effects models, stratified by subgroup, and assessment of heterogeneity.
Main Results:
- Twenty-three studies were included, revealing significant variability in prevalence based on assessment tools.
- Self-report questionnaires indicated a pooled prevalence of 13.60%, while physician diagnoses showed 2.84%.
- The Nine-Item Avoidant/Restrictive Food Intake Disorder Screen yielded the highest prevalence at 17.10%; no significant differences were found based on sex, IBD subtype, age, or disease activity.
Conclusions:
- Eating disorders, particularly avoidant/restrictive types, are prevalent in individuals with IBD.
- The findings underscore the necessity for enhanced screening protocols and heightened clinical awareness for disordered eating in the IBD patient cohort.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

